This company listing is no longer active
ANHG.Y Stock Overview
Mediclinic International plc, together with its subsidiaries, operates private hospitals. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Mediclinic International plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£5.49 |
52 Week High | UK£5.58 |
52 Week Low | UK£5.49 |
Beta | 0.48 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -59.69% |
Recent News & Updates
Recent updates
Shareholder Returns
ANHG.Y | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 1.6% | 2.2% |
1Y | n/a | 2.1% | 31.6% |
Return vs Industry: Insufficient data to determine how ANHG.Y performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how ANHG.Y performed against the US Market.
Price Volatility
ANHG.Y volatility | |
---|---|
ANHG.Y Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.8% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ANHG.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ANHG.Y's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 33,683 | Ronnie van der Merwe | www.mediclinic.com |
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom.
Mediclinic International plc Fundamentals Summary
ANHG.Y fundamental statistics | |
---|---|
Market cap | US$4.08b |
Earnings (TTM) | US$169.25m |
Revenue (TTM) | US$3.62b |
24.1x
P/E Ratio1.1x
P/S RatioIs ANHG.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ANHG.Y income statement (TTM) | |
---|---|
Revenue | UK£3.23b |
Cost of Revenue | UK£2.53b |
Gross Profit | UK£706.00m |
Other Expenses | UK£555.00m |
Earnings | UK£151.00m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Nov 16, 2022
Earnings per share (EPS) | 0.20 |
Gross Margin | 21.84% |
Net Profit Margin | 4.67% |
Debt/Equity Ratio | 55.6% |
How did ANHG.Y perform over the long term?
See historical performance and comparison